Review



human panc1 male cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC human panc1 male cells
    (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and <t>PANC1</t> cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Human Panc1 Male Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8508 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human panc1 male cells/product/ATCC
    Average 99 stars, based on 8508 article reviews
    human panc1 male cells - by Bioz Stars, 2026-04
    99/100 stars

    Images

    1) Product Images from "Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells"

    Article Title: Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells

    Journal: Cell reports

    doi: 10.1016/j.celrep.2021.110236

    (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and PANC1 cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Figure Legend Snippet: (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and PANC1 cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Techniques Used: Liquid Chromatography with Mass Spectroscopy

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Virus, Microarray, Recombinant, Lysis, Protease Inhibitor, Membrane, Saline, Autoradiography, Plasmid Preparation, Control, BIA-KA, Reverse Transcription, Enzyme-linked Immunosorbent Assay, Expressing, Software, Mass Spectrometry, Targeted Proteomics, Real-time Polymerase Chain Reaction, Live Cell Imaging



    Similar Products

    human panc1 male cells  (ATCC)
    99
    ATCC human panc1 male cells
    (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and <t>PANC1</t> cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
    Human Panc1 Male Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human panc1 male cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human panc1 male cells - by Bioz Stars, 2026-04
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and PANC1 cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Journal: Cell reports

    Article Title: Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells

    doi: 10.1016/j.celrep.2021.110236

    Figure Lengend Snippet: (A) Principal-component analysis (PCA) of fold changes in 485 metabolites measured by LC-MS in SUIT2, YAPC, and PANC1 cells treated ±100 U/mL IFNβ for 24 h (n = 6). Numbers and percentages of metabolites significantly altered by IFNβ treatment are indicated (FDR ≤ 10%). (B) Metabolite set enrichment analysis (MSEA) of significantly altered metabolites in each cell line. (C) Summary of IFN-induced alterations in nucleotide and NAD+/NADH metabolism in SUIT2 cells. (D) Relative levels of indicated metabolites in PDAC cell lines treated ±100 U/mL IFNβ for 24 h (mean ± SD, n = 6, unpaired t test). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

    Article Snippet: Human PANC1 (male) cells , ATCC , Cat#CRL1469; RRID:CVCL_0480.

    Techniques: Liquid Chromatography with Mass Spectroscopy

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells

    doi: 10.1016/j.celrep.2021.110236

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: Human PANC1 (male) cells , ATCC , Cat#CRL1469; RRID:CVCL_0480.

    Techniques: Virus, Microarray, Recombinant, Lysis, Protease Inhibitor, Membrane, Saline, Autoradiography, Plasmid Preparation, Control, BIA-KA, Reverse Transcription, Enzyme-linked Immunosorbent Assay, Expressing, Software, Mass Spectrometry, Targeted Proteomics, Real-time Polymerase Chain Reaction, Live Cell Imaging